Abstract

• Calcium carbonate-hybridized nanocarrier achieved acid-responsive release of cargo. • PEGylated multi-armed PLGA has high drug loading and immune escape functions. • The improvement in arthritis involved regulating the VEGF, JAK2 and STAT3 pathways. • Peach gum will become an alternative for dissolving microneedle substrates. • Functionalized nanoparticles integrated with microneedles enhanced drug delivery. The low drug-loading and permeation enhancement abilities of PLGA nanoparticles limit their use as transdermal delivery vehicles. We recently designed PEGylated star-shaped PLGA, which hybridized with calcium carbonate to form nanoparticles [6 s-NPs (CaCO 3 )] with immune stealth and acid-responsive properties, which increased the loading of tetrandrine (Tet), a poorly soluble antiarthritis active ingredient, by 3.26-fold compared with that of single-chain PLGA nanoparticles. The 6 s-NPs (CaCO 3 ) resulted in acid-responsive release of more cargo in both in vitro release medium (pH 5.5) and fibroblast-like synoviocytes (FLSs) ( p < 0.0001), thereby inducing stronger cytotoxic effects of the loaded Tet on the TNF-α-induced abnormal proliferation of FLSs than Tet-loaded 6 s-NPs (no CaCO 3 ) and Tet aqueous dispersion (Free Tet) ( p < 0.0001). However, the number of 6 s-NPs (CaCO 3 ) incorporated by RAW264.7 cells was significantly lower than that of PLGA nanoparticles without PEGylation-endowed immune escape function. Furthermore, the nanoparticles were integrated into peach gum-fabricated dissolving microneedles with higher mechanical hardness and better physical stability than hyaluronic acid-formed microneedles. This integrated delivery strategy dramatically increased synovial uptake of Tet via the transdermal route and was further enhanced by the cofunctionalization with stealth escape from phagocytes and inflammatory acidity-triggered release. The observed improvement in adjuvant-induced arthritis involved stronger regulation of the VEGF, JAK2/p-JAK2, and STAT3/p-STAT3 pathways, which was superior to deleting certain currently designed delivery capacities. This newly fabricated multifunctional transdermal vehicle is therefore a promising therapeutic approach for protecting against local inflammation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.